Elicio Therapeutics raised $6.0 million in a private placement financing led by GKCC, LLC to advance its development pipeline and for working capital and general corporate purposes.
Amount Raised
$6 Million
Round Type
Post-IPO Equity
BostonBiotechnologyInvestors
Description
Elicio Therapeutics, a clinical-stage biotechnology company, announced a private placement financing of approximately $6.0 million. The financing was led by GKCC, LLC, an entity controlled by a member of Elicio’s Board of Directors, and is expected to be used for the advancement of its development pipeline, as well as for working capital and general corporate purposes.
Quick answer
Elicio Therapeutics raised $6 Million in a Post-IPO Equity round, dated March 19, 2024. Investors: Gkcc, Llc. Elicio Therapeutics is based in Boston, Massachusetts, United States.
- How much did Elicio Therapeutics raise?
- Elicio Therapeutics raised $6 Million in a Post-IPO Equity round on March 19, 2024.
- Who invested in Elicio Therapeutics?
- Gkcc, Llc is named as investors in this round.
- What does Elicio Therapeutics do?
- Elicio Therapeutics is a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer.
- Where is Elicio Therapeutics based and how big is it?
- Elicio Therapeutics is based in Boston, Massachusetts, United States. Fundz records about 42 employees.
- Who are the decision-makers at Elicio Therapeutics?
- Fundz holds 1 contact at Elicio Therapeutics, including the Chief Scientific Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Elicio Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Allozymes raised $15M (Series A) on May 3, 2024.
- Acclinate raised $6M on May 3, 2024.
- BridgeBio raised $200M (Pre-Seed) on May 3, 2024.
- API Holdings raised $216M (Private Equity) on May 3, 2024.
- Zenas BioPharma raised $200M on May 3, 2024.
- Enrich Biosystems raised $750K (Seed) on May 3, 2024.
Who to call at Elicio Therapeutics, and when
A new round usually means Elicio Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Elicio Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Elicio Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Elicio Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Elicio Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Elicio Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.